Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
TDOC logo TDOC
Upturn stock ratingUpturn stock rating
TDOC logo

Teladoc Inc (TDOC)

Upturn stock ratingUpturn stock rating
$10.99
Delayed price
Profit since last BUY-0.09%
upturn advisory
WEAK BUY
BUY since 15 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/26/2025: TDOC (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -45.45%
Avg. Invested days 27
Today’s Advisory WEAK BUY
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/26/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.41B USD
Price to earnings Ratio -
1Y Target Price 10.64
Price to earnings Ratio -
1Y Target Price 10.64
Volume (30-day avg) 9081815
Beta 1.27
52 Weeks Range 6.76 - 15.21
Updated Date 04/1/2025
52 Weeks Range 6.76 - 15.21
Updated Date 04/1/2025
Dividends yield (FY) -
Basic EPS (TTM) -5.87

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -38.97%
Operating Margin (TTM) -6.58%

Management Effectiveness

Return on Assets (TTM) -3.3%
Return on Equity (TTM) -52.46%

Valuation

Trailing PE -
Forward PE 357.14
Enterprise Value 1668715374
Price to Sales(TTM) 0.55
Enterprise Value 1668715374
Price to Sales(TTM) 0.55
Enterprise Value to Revenue 0.65
Enterprise Value to EBITDA 12.16
Shares Outstanding 173672000
Shares Floating 159594177
Shares Outstanding 173672000
Shares Floating 159594177
Percent Insiders 0.84
Percent Institutions 75.9

Analyst Ratings

Rating 3.36
Target Price 10.95
Buy 3
Strong Buy 3
Buy 3
Strong Buy 3
Hold 19
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Teladoc Inc

stock logo

Company Overview

overview logo History and Background

Teladoc Inc. was founded in 2002 as Teladoc Medical Services. It pioneered telehealth by connecting patients and doctors remotely. Over time, it expanded its services through acquisitions and partnerships, becoming a leading global provider of virtual care.

business area logo Core Business Areas

  • Teladoc Health Integrated Care: Provides a comprehensive suite of virtual care services, including general medical, mental health, and specialty care. It focuses on delivering personalized and integrated care experiences to improve health outcomes and reduce healthcare costs for individuals and employers. Integrated Care includes BetterHelp.
  • BetterHelp: Offers direct-to-consumer mental health services through online therapy and counseling. It connects individuals with licensed therapists for convenient and affordable mental health support. As the market continues to grow at around 20-30% per year, many expect Teladoc to continue to grow with the market, and many believe that this segment of their business will be profitable.

leadership logo Leadership and Structure

Jason Gorevic is the Chief Executive Officer. The organizational structure is composed of various departments, including technology, operations, finance, and marketing, each headed by senior executives who report to the CEO.

Top Products and Market Share

overview logo Key Offerings

  • General Medical: Virtual doctor visits for common illnesses and injuries. Competitors include Amwell (AMWL), MDLive (owned by Cigna), and Doctor On Demand (owned by Included Health). Teladoc leads the general medical market but exact market share is difficult to pinpoint as it is not publicly revealed. In 2023, Teladoc performed 4.1 million general medical visits.
  • Mental Health (BetterHelp): Online therapy and counseling services connecting individuals with licensed therapists. Key competitors include Talkspace (TALK) and Cerebral. In 2023, BetterHelp generated 1 Billion USD in revenue, but has not yet been profitable.
  • Chronic Care Management: Programs for managing chronic conditions such as diabetes and hypertension. Livongo was a large competitor and was eventually acquired in 2020.

Market Dynamics

industry overview logo Industry Overview

The telehealth industry is experiencing rapid growth, driven by increasing demand for convenient, accessible, and affordable healthcare solutions. Key trends include the adoption of virtual care by employers and health plans, advancements in technology, and regulatory changes that support telehealth expansion.

Positioning

Teladoc Inc. is positioned as a market leader in the telehealth industry. Its competitive advantages include its broad range of services, large provider network, established brand recognition, and technology platform. However, increased competition from other telehealth providers and traditional healthcare companies poses a challenge.

Total Addressable Market (TAM)

The global telehealth market is expected to reach USD 455.3 billion by 2030. Teladoc is well-positioned to capture a significant portion of this TAM through its comprehensive service offerings and established market presence.

Upturn SWOT Analysis

Strengths

  • Brand recognition
  • Broad service portfolio
  • Extensive provider network
  • Established technology platform
  • Large customer base

Weaknesses

  • Profitability struggles
  • Integration issues post acquisitions
  • High marketing spend
  • Customer acquisition costs

Opportunities

  • Expanding telehealth adoption
  • Strategic partnerships with health plans
  • Growing demand for mental health services
  • Technological advancements
  • International expansion

Threats

  • Increased competition
  • Regulatory uncertainty
  • Reimbursement challenges
  • Data privacy concerns
  • Economic downturn

Competitors and Market Share

competitor logo Key Competitors

  • AMWL
  • TALK
  • CERE

Competitive Landscape

Teladoc has a larger range of services than most competitors, but many of the competitors are profitable while Teladoc currently is not. Increased marketing costs have eaten up a lot of potential profit and will need to be addressed.

Major Acquisitions

Livongo

  • Year: 2020
  • Acquisition Price (USD millions): 18500
  • Strategic Rationale: Acquisition was for chronic care management, expanding service offerings and customer base. Has not yet proven to be profitable and has lost the company billions due to poor performance.

Growth Trajectory and Initiatives

Historical Growth: Teladoc has experienced strong revenue growth historically, driven by increasing adoption of telehealth services.

Future Projections: Analysts project continued revenue growth for Teladoc, driven by expanding telehealth adoption and strategic initiatives. However, profitability remains a key challenge.

Recent Initiatives: Recent initiatives include expanding into new markets, launching new services, and investing in technology to enhance the user experience.

Summary

Teladoc is a leader in the telehealth industry with a wide range of services. Although the company has strong revenue growth, they are still not profitable. Marketing costs need to be addressed to grow the bottom line. Teladoc needs to maintain its market position and focus on profitability to continue to grow the business.

Similar Companies

AMWLratingrating

American Well Corp

$8.14
Small-Cap Stock
0%
PASS

AMWLratingrating

American Well Corp

$8.14
Small-Cap Stock
0%
PASS

CEREratingrating

Cerevel Therapeutics Holdings Inc

$44.96
Mid-Cap Stock
1.26%
STRONG BUY
BUY since 5 days

CEREratingrating

Cerevel Therapeutics Holdings Inc

$44.96
Mid-Cap Stock
BUY since 5 days
1.26%
STRONG BUY

CVSratingrating

CVS Health Corp

$65.23
Large-Cap Stock
14.64%
Consider higher Upturn Star rating
BUY since 28 days

CVSratingrating

CVS Health Corp

$65.23
Large-Cap Stock
BUY since 28 days
14.64%
Consider higher Upturn Star rating

TALKratingrating

Talkspace Inc

$2.66
Small-Cap Stock
0%
PASS

TALKratingrating

Talkspace Inc

$2.66
Small-Cap Stock
0%
PASS

UNHratingrating

UnitedHealth Group Incorporated

$511.3
Large-Cap Stock
0%
PASS

UNHratingrating

UnitedHealth Group Incorporated

$511.3
Large-Cap Stock
0%
PASS

Sources and Disclaimers

Data Sources:

  • Company filings (10-K, 10-Q)
  • Investor presentations
  • Analyst reports
  • Industry reports

Disclaimers:

This analysis is for informational purposes only and should not be considered investment advice. Data may be subject to change. Market share estimates are approximate.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Teladoc Inc

Exchange NYSE
Headquaters Purchase, NY, United States
IPO Launch date 2015-07-01
CEO & Director Mr. Charles Divita III, CPA
Sector Healthcare
Industry Health Information Services
Full time employees 4620
Full time employees 4620

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​